ZA200203069B - Peptides for treatment of erectile dysfunction. - Google Patents

Peptides for treatment of erectile dysfunction.

Info

Publication number
ZA200203069B
ZA200203069B ZA200203069A ZA200203069A ZA200203069B ZA 200203069 B ZA200203069 B ZA 200203069B ZA 200203069 A ZA200203069 A ZA 200203069A ZA 200203069 A ZA200203069 A ZA 200203069A ZA 200203069 B ZA200203069 B ZA 200203069B
Authority
ZA
South Africa
Prior art keywords
peptides
treatment
erectile dysfunction
erectile
dysfunction
Prior art date
Application number
ZA200203069A
Other languages
English (en)
Inventor
Antonio Argiolas
Romano Deghenghi
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of ZA200203069B publication Critical patent/ZA200203069B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA200203069A 1999-11-10 2002-04-18 Peptides for treatment of erectile dysfunction. ZA200203069B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/437,147 US6211156B1 (en) 1999-11-10 1999-11-10 Peptides for treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
ZA200203069B true ZA200203069B (en) 2002-11-27

Family

ID=23735278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203069A ZA200203069B (en) 1999-11-10 2002-04-18 Peptides for treatment of erectile dysfunction.

Country Status (23)

Country Link
US (1) US6211156B1 (ru)
EP (1) EP1246836A2 (ru)
JP (1) JP2003513930A (ru)
KR (1) KR20020058003A (ru)
CN (1) CN1255426C (ru)
AR (1) AR026434A1 (ru)
AU (1) AU776994B2 (ru)
BG (1) BG106735A (ru)
BR (1) BR0015446A (ru)
CA (1) CA2390854A1 (ru)
CZ (1) CZ20021539A3 (ru)
HK (1) HK1050205A1 (ru)
HU (1) HUP0203181A3 (ru)
IL (1) IL149200A0 (ru)
MX (1) MXPA02004118A (ru)
NO (1) NO20022101D0 (ru)
NZ (1) NZ519062A (ru)
PL (1) PL354613A1 (ru)
RU (1) RU2264823C2 (ru)
SK (1) SK6222002A3 (ru)
UA (1) UA74170C2 (ru)
WO (1) WO2001034171A2 (ru)
ZA (1) ZA200203069B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10344848A1 (de) * 2003-09-26 2005-04-14 Solvay Pharmaceuticals Gmbh Amidomethyl-substituierte l-(Carboxyalkyl)-cyclopentylcarbonylamino-benzazepin-N-essigsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enhaltende Arzneimittel
CN101302246B (zh) * 2007-05-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 黑色素皮质激素受体七肽类激动剂及其制备方法和用途
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5872100A (en) * 1990-05-11 1999-02-16 Deghenghi; Romano Peptides containing D-2-Alkyl-Tryptophan
JP3204510B2 (ja) * 1993-04-05 2001-09-04 コンペティティブ テクノロジーズ,インク. 勃起不全の診断および治療
EP0783521B8 (en) * 1994-09-27 2003-04-09 Ardana Bioscience Limited Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
CA2158425C (en) * 1995-09-15 2003-01-28 Mac E. Hadley Diagnostic and treatment of erectile dysfunction
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
US5807985A (en) * 1996-06-11 1998-09-15 Deghenghi; Romano Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US5932548A (en) * 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
US6124263A (en) * 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Also Published As

Publication number Publication date
WO2001034171A2 (en) 2001-05-17
CA2390854A1 (en) 2001-05-17
UA74170C2 (ru) 2005-11-15
AR026434A1 (es) 2003-02-12
CN1255426C (zh) 2006-05-10
RU2002115662A (ru) 2004-01-27
BG106735A (bg) 2003-02-28
AU776994B2 (en) 2004-09-30
KR20020058003A (ko) 2002-07-12
US6211156B1 (en) 2001-04-03
BR0015446A (pt) 2002-07-09
NO20022101L (no) 2002-05-02
CN1390230A (zh) 2003-01-08
IL149200A0 (en) 2002-11-10
WO2001034171A3 (en) 2001-12-13
RU2264823C2 (ru) 2005-11-27
CZ20021539A3 (cs) 2003-08-13
HUP0203181A3 (en) 2003-11-28
HUP0203181A2 (hu) 2003-02-28
JP2003513930A (ja) 2003-04-15
EP1246836A2 (en) 2002-10-09
AU1278601A (en) 2001-06-06
NZ519062A (en) 2003-10-31
SK6222002A3 (en) 2004-03-02
PL354613A1 (en) 2004-02-09
HK1050205A1 (zh) 2003-06-13
MXPA02004118A (es) 2003-02-12
NO20022101D0 (no) 2002-05-02

Similar Documents

Publication Publication Date Title
IL141553A0 (en) Drug preparations for treating sexual dysfunction
ZA200107291B (en) Use of xenon for treating neurointoxications.
GB9608408D0 (en) Treatment of erectile dysfunction
GC0000096A (en) Treatment of female sexual dysfunction.
IL138907A0 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
EP1027054A4 (en) LOCAL CONTRIBUTION OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION
AU4583899A (en) Nasal administration of sildenafil for the treatment of erectile dysfunction
ZA200108446B (en) Novel method of treatment.
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
HUP0200079A3 (en) Treatment of infertility
ZA9811507B (en) Combination effective for the treatment of impotence.
HUP0200157A3 (en) Treatment of infertility
AU2001274649A1 (en) Topical preparation of alprostadil for the treatment of erectile dysfunction
AU3048501A (en) An improved pharmaceutical composition for treating male erectile dysfunction
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
EP1161255A4 (en) METHOD AND MEANS FOR TREATING ERECTILE DYSFUNCTION
ZA200203069B (en) Peptides for treatment of erectile dysfunction.
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
ZA200105259B (en) Use of growth hormone secretagogues for stimulating or increasing appetite.
ZA200203166B (en) Treatment of cancer.
HK1042039A1 (en) Use of phanquinone for the treatment or preventionof memory impairment.
ZA992793B (en) Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.
ZA200006376B (en) Compounds for the treatment of female sexual dysfunction.